{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Membrane Transporter & Ion Channel > Dapagliflozin Propanediol MonohydrateCAS：960404-48-2
Molecular Formula：C21H25ClO6·C3H8O2·H2O
Molecular Weight：502.98
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to yellow Solid
Qty：
Size：
| CAS | 960404-48-2 |
| Name | Dapagliflozin Propanediol Monohydrate |
| Molecular Formula | C21H25ClO6·C3H8O2·H2O |
| Molecular Weight | 502.98 |
| Solubility | Soluble in DMSO ≥10mg/mL |
| Purity | ≥98% |
| Appearance | White to yellow Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 811-335-4 |
| SMILES | O[C@H]1[C@H](C2=CC(CC3=CC=C(OCC)C=C3)=C(Cl)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O.C[C@H](O)CO.O |
| Target Point | SGLT2 |
| Passage | Membrane Transporter&Ion Channel |
| Background | Dapagliflozin Propanediol Monohydrate is a competitive sodium/glucose co-transporter 2 (SGLT2) inhibitor |
| Biological Activity | Dapagliflozin propanediol belongs to the class of orally administered antidiabetic agents designated as sodiumglucose cotransporter 2 (SGLT2) inhibitors.[1] |
| Data Literature Source | [1] Reilly TP，et al. Diabetes Ther. 2014，5(1):73-96. |
| Unit | Bottle |
| Specification | 5mg 10mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
